Exact Sciences Corporation, headquartered in the United States, is a leading player in the molecular diagnostics industry, specialising in cancer screening and diagnostic solutions. Founded in 1995, the company has achieved significant milestones, including the development of its flagship product, Cologuard, a non-invasive stool DNA test for colorectal cancer screening, which has transformed early detection practices. With a strong focus on innovation, Exact Sciences also offers a range of genomic testing services aimed at improving patient outcomes. The company has established a robust market position, recognised for its commitment to advancing cancer care through cutting-edge technology and research. Its unique approach to diagnostics not only enhances screening accuracy but also empowers patients and healthcare providers alike.
How does Exact Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Exact Sciences's score of 38 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Exact Sciences reported total carbon emissions of approximately 145,112 kg CO2e, with emissions distributed across Scope 1, 2, and 3. Specifically, Scope 1 emissions accounted for about 3,075 kg CO2e, while Scope 2 emissions were approximately 13,993 kg CO2e. The majority of emissions, around 128,045 kg CO2e, fell under Scope 3, which includes significant contributions from business travel (43,691 kg CO2e) and employee commuting (69,623 kg CO2e). For the year 2023, Exact Sciences disclosed total emissions of approximately 3,100,000 kg CO2e. This figure included Scope 1 emissions of about 12,177,000 kg CO2e, Scope 2 emissions of approximately 312,000 kg CO2e, and Scope 3 emissions of around 6,930,000 kg CO2e, with business travel alone contributing about 5,002,000 kg CO2e. Exact Sciences has committed to near-term carbon reduction targets, although specific numerical targets have not been disclosed. The company is actively engaged in climate initiatives, as indicated by its commitment status with the Science Based Targets initiative (SBTi). However, it has not yet set a net-zero target. The emissions data and climate commitments are sourced directly from Exact Sciences Corporation, reflecting its corporate responsibility towards reducing carbon footprints and addressing climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 161,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 3,540,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 |
Exact Sciences's Scope 3 emissions, which decreased by 19% last year and increased by approximately 96% since 2019, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 36% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 72% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Exact Sciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Exact Sciences's sustainability data and climate commitments